Gallagher Kathleen P. bought RNA
January 6, 2025 · Form 4 insider transaction
Gallagher Kathleen P. bought 50,000 shares of Atrium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderGallagher Kathleen P.
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2025
Filing dateJanuary 8, 2025
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests in 48 equal installments on each monthly anniversary of the grant date, until it is fully vested on January 6, 2029.